SELECT ISSUE

MÆDICA - a Journal of Clinical Medicine | Vol. 8, nr. 4, 2013

ISSN 1841-9038  |  e-ISSN 2069-6116
ISSN-L 1841-9038
CNCSIS - CMR - B+

HIGHLIGHTS

Plagiatul – in actualitate

Tema plagiatului este tot mai mult discutata in ultima vreme. Aparitia unor programe performante de cautare si identificare a similitudinilor intre texte [...]

Committe on Publication Ethics

A forum for responsible and ethical research publishing – Code of Conduct and Best Practice Guidelines for Journal Editors.

Members Area


Secondary Acute Lymphoblastic Leukemia after Hodgkin’s Lymphoma or a Coincidental Association of Two Hematological Malignancies?

, , , and

ABSTRACT

Secondary acute lymphoblastic leukaemia (sALL), defined as acute lymphoblastic leukaemia following another malignancy, irrespective of previous treatment, is a rare disease, and its biological characteristics have not been accurately described. We report the case of a 24-year old patient followed for Hodgkin’s lymphoma at our clinic, who develops and is diagnosed, less than a year after obtaining complete remission, as having pro-B acute lymphoblastic leukaemia This case has been a real diagnostic and treatment challenge, as sALL following another haematological malignancy is quite rare. Conclusion: It is necessary to better identify the prognostic factors of haematological malignancies in order to prevent the appearance of sALL.

Keywords: secondary acute leukaemia, Hodgkin’s lymphoma, immunophenotyping, 11q23 mutation, alkilating agents, prognostic factors

Full text | PDF